|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.765 USD | -1.75% |
|
+15.73% | -38.54% |
| 07-07 | RBC Capital Adjusts Verastem Price Target to $14 From $15, Maintains Outperform Rating | MT |
| 06-29 | Verastem, Inc.(NasdaqCM:VSTM) dropped from Russell Small Cap Comp Value Benchmark | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| VERASTEM, INC. | Bio Therapeutic Drugs | -1.96% | +15.73% | -38.54% | +0.74% | -89.23% | 426M |  |  | |
- Stock Market
- Stocks
- VSTM Stock
- Charts Verastem, Inc.
- Comparison Chart
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
